The associations between high MCL-1 and poor outcome, along with the observed frequent amplification of MCL1 in breast cancer may reflect a requirement for MCL-1 in the oncogenic process as has been observed in haematopoietic cancers32–35. The gene discussed is MCL1; the disease is breast carcinoma.